Zoetis Inc
NYSE:ZTS
Zoetis Inc
Net Income (Common)
Zoetis Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zoetis Inc
NYSE:ZTS
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$40.6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
$8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
$2.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-21%
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$365m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-22%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
See Also
What is Zoetis Inc's Net Income (Common)?
Net Income (Common)
2.3B
USD
Based on the financial report for Dec 31, 2023, Zoetis Inc's Net Income (Common) amounts to 2.3B USD.
What is Zoetis Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
17%
Over the last year, the Net Income (Common) growth was 11%. The average annual Net Income (Common) growth rates for Zoetis Inc have been 13% over the past three years , 10% over the past five years , and 17% over the past ten years .